Beyond The Printed Page
2023 Manufacturing And Supply Chain Outlook: Additional Insights
Additional executive responses to our 2023 manufacturing and supply chain outlook questions.
2023 Finance And Funding Outlook: Additional Insights Part 2
Additional experts weigh in on Life Science Leader's 2023 finance and funding outlook questions.
2023 Finance And Funding Outlook: Additional Insights Part 1
Biopharma executives offer options, tips and strategies for navigating finance and funding challenges in 2023.
Big Pharma CEOs Discuss Collaboration, Talent And IRA Implications At Galien Forum
This article is part two of a two-part series covering the highlights of the Galien Forum. Part 1 can be accessed here.
Industry Leaders Talk Pricing, Accelerated Approval, Diversity At Galien Forum
Part one of a two-part series covering highlights from the Galien Forum in New York City, held on October 27.
MAPS: Walking The Talk On Intellectual Property?
Did MAPS, a leader in the psychedelic medicines space, just make good on its promise to share its intellectual property, as opposed to wielding it against competitors?
Where Patients Meet Policy: The EveryLife Foundation For Rare Diseases
The year before he founded Ultragenyx, Emil Kakkis created the EveryLife Foundation for Rare Diseases, a nonprofit patient advocacy organization focused on the “equitable development of and access to lifesaving diagnoses, treatments, and cures.” We caught up with Annie Kennedy, chief of policy and advocacy at the EveryLife Foundation, to learn more about the issues and policies the foundation is prioritizing this year.
Ever Learn A Lesson The Hard Way?
Bernard Coulie, M.D., Ph.D., president and CEO of Pliant Therapeutics, a company developing treatments for fibrotic diseases, shares a lesson learned the hard way involving an exit from a previous startup.
Starting A Company … In Another Country
Bernard Coulie, M.D., Ph.D., president and CEO of Pliant Therapeutics, a company developing treatments for fibrotic diseases, discusses challenges associated with building a biopharma startup in another country.
A Lesson In Leadership From Lara Sullivan
Lara Sullivan, M.D., CEO of Pyxis Oncology, shares a story showing the impact had by employees in creating the right corporate culture.